InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ROCKWELL MEDICAL, INC.

RMTI Clue Score35
United States Fiscal year ends December CIK 0001041024
$7.89 -1.62% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.89 +1,291.04% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−20.2Net income−19.8EPS, diluted−0.39Fiscal year 2017Revenue57.3Operating income−25.9Net income−25.9EPS, diluted−0.51Fiscal year 2018Revenue63.4 +10.6%Operating income−32.4Net income−32.1Fiscal year 2019Revenue61.3 −3.3%Operating income−34.5Net income−34.1Fiscal year 2020Revenue62.2 +1.5%Operating income−28.4Net income−30.9EPS, diluted−0.41Fiscal year 2021Revenue61.9 −0.4%Operating income−30.3Net income−32.7EPS, diluted−3.83Fiscal year 2022Revenue72.8 +17.6%Operating income−16.8Net income−18.7EPS, diluted−1.31Fiscal year 2023Revenue83.6 +14.8%Operating income−6.7Net income−8.4EPS, diluted−0.37Fiscal year 2024Revenue101.5 +21.4%Operating income0.6Net income−0.5EPS, diluted−0.03Fiscal year 2025Revenue69.3 −31.8%Operating income−4.7Net income−5.3EPS, diluted−0.15
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 57.3 63.4 61.3 62.2 61.9 72.8 83.6 101.5 69.3
Growth +10.6% −3.3% +1.5% −0.4% +17.6% +14.8% +21.4% −31.8%
Operating income −20.2 −25.9 −32.4 −34.5 −28.4 −30.3 −16.8 −6.7 0.6 −4.7
Net income −19.8 −25.9 −32.1 −34.1 −30.9 −32.7 −18.7 −8.4 −0.5 −5.3
Growth
EPS, diluted −0.39 −0.51 n/a n/a −0.41 −3.83 −1.31 −0.37 −0.03 −0.15

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Gross margin6.5%Operating margin−45.2%Net margin−45.2%Fiscal year 2018Gross margin−2.5%Operating margin−51.2%Net margin−50.7%Fiscal year 2019Gross margin4.6%Operating margin−56.3%Net margin−55.7%Fiscal year 2020Gross margin4.4%Operating margin−45.7%Net margin−49.7%Fiscal year 2021Gross margin−3.9%Operating margin−49.0%Net margin−52.8%Fiscal year 2022Gross margin5.6%Operating margin−23.0%Net margin−25.7%Fiscal year 2023Gross margin10.4%Operating margin−8.0%Net margin−10.1%Free cash flow margin−11.6%Fiscal year 2024Gross margin17.2%Operating margin0.6%Net margin−0.5%Free cash flow margin3.1%Fiscal year 2025Gross margin16.9%Operating margin−6.8%Net margin−7.7%Free cash flow margin−1.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 6.5% −2.5% 4.6% 4.4% −3.9% 5.6% 10.4% 17.2% 16.9%
Operating margin n/a −45.2% −51.2% −56.3% −45.7% −49.0% −23.0% −8.0% 0.6% −6.8%
Net margin n/a −45.2% −50.7% −55.7% −49.7% −52.8% −25.7% −10.1% −0.5% −7.7%
Free cash flow margin n/a n/a n/a n/a n/a n/a n/a −11.6% 3.1% −1.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−12.5Fiscal year 2017Operating cash flow−21.1Fiscal year 2018Operating cash flow−20.4Fiscal year 2019Operating cash flow−27.3Fiscal year 2020Operating cash flow−29.6Fiscal year 2021Operating cash flow−33.5Fiscal year 2022Operating cash flow−16.9Fiscal year 2023Operating cash flow−9.4Capital expenditure−0.3Free cash flow−9.7Fiscal year 2024Operating cash flow4.2Capital expenditure−1.0Free cash flow3.2Fiscal year 2025Operating cash flow−0.7Capital expenditure−0.5Free cash flow−1.2 −137.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −12.5 −21.1 −20.4 −27.3 −29.6 −33.5 −16.9 −9.4 4.2 −0.7
Capital expenditure n/a n/a n/a n/a n/a n/a n/a −0.3 −1.0 −0.5
Free cash flow n/a n/a n/a n/a n/a n/a n/a −9.7 3.2 −1.2
Growth −137.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash17.2Shareholders’ equity53.0Fiscal year 2017Cash8.4Shareholders’ equity32.9Fiscal year 2018Cash22.7Shareholders’ equity27.3Fiscal year 2019Cash11.8Total debt0.0Net cash (debt)11.8Shareholders’ equity20.3Debt to equity0.00Fiscal year 2020Cash48.7Total debt20.9Net cash (debt)27.7Shareholders’ equity34.2Debt to equity0.61Fiscal year 2021Cash13.3Total debt20.6Net cash (debt)−7.3Shareholders’ equity2.5Debt to equity8.11Fiscal year 2022Cash10.1Total debt9.2Net cash (debt)0.9Shareholders’ equity14.1Debt to equity0.65Fiscal year 2023Cash9.0Total debt8.3Net cash (debt)0.7Shareholders’ equity21.3Debt to equity0.39Fiscal year 2024Cash15.7Total debt8.5Net cash (debt)7.2Shareholders’ equity32.6Debt to equity0.26Fiscal year 2025Cash10.7Total debt8.8Net cash (debt)1.9Shareholders’ equity37.0Debt to equity0.24
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 17.2 8.4 22.7 11.8 48.7 13.3 10.1 9.0 15.7 10.7
Total debt n/a n/a n/a 0.0 20.9 20.6 9.2 8.3 8.5 8.8
Net cash (debt) n/a n/a n/a 11.8 27.7 −7.3 0.9 0.7 7.2 1.9
Shareholders’ equity 53.0 32.9 27.3 20.3 34.2 2.5 14.1 21.3 32.6 37.0
Debt to equity n/a n/a n/a 0.00 0.61 8.11 0.65 0.39 0.26 0.24

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
17.2 8.4 22.7 11.8 48.7 13.3 10.1 9.0 15.7 10.7
6.4 6.4 7.0 4.2 4.2 5.9 6.3 10.9 8.3 8.1
12.1 7.6 4.0 3.6 3.9 4.1 5.8 5.9 5.8 3.4
1.4 2.5 2.6 2.4 2.6 2.5 2.2 6.4 5.8 4.6
0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9
83.2 58.8 52.6 44.3 77.7 48.6 46.6 52.2 59.2 57.1
Growth −29.3% −10.6% −15.7% +75.4% −37.5% −4.0% +11.9% +13.5% −3.5%
Liabilities
n/a n/a n/a n/a 0.0 7.4 1.6 0.0 n/a 0.0
n/a n/a n/a 0.0 20.9 13.2 7.6 8.3 8.5 8.8
calc n/a n/a n/a 0.0 20.9 20.6 9.2 8.3 8.5 8.8
n/a 25.9 25.3 24.0 43.6 46.0 32.5 30.9 26.6 20.2
Equity
−214.3 −240.3 −272.4 −306.5 −337.4 −370.1 −388.8 −397.2 −397.7 −403.0
53.0 32.9 27.3 20.3 34.2 2.5 14.1 21.3 32.6 37.0
Growth −37.8% −17.1% −25.5% +68.2% −92.6% +456.4% +50.9% +53.1% +13.5%
Per share and net cash
calc n/a n/a n/a 11.8 27.7 −7.3 0.9 0.7 7.2 1.9
51.5 51.8 57.0 65.4 93.6 8.5 12.2 29.1 34.1 39.4
calc 1.03 0.64 0.48 0.31 0.37 0.30 1.16 0.73 0.96 0.94

† The diluted share count jumps at 2021 and 2022 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.